Latest Chemotherapy regimens Stories
- Data support VAL-083's importance as a potential therapy for non-small cell lung cancer (NSCLC), including drug-resistant NSCLC - VANCOUVER, British Columbia and MENLO PARK, Calif.,
Important Step Towards Increasing Treatment Options for Patients With This Serious Disease THOUSAND OAKS, Calif., April 6, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the
THOUSAND OAKS, Calif., Feb.
LUGANO, Switzerland and COPENHAGEN, Denmark, February 5, 2015 /PRNewswire/ -- - Elsiglutide is a GLP-2 receptor agonist with potential as a first-ever therapy to help cancer
Exploratory Analysis of Phase 2 Trial Shows Earlier and Sustained Responses in Patients Treated With Vectibix Versus Bevacizumab THOUSAND OAKS, Calif., Jan.
Oncologists now have a new understanding of the toxicity levels of specific chemotherapy regimens used for women with early stage breast cancer.
Vectibix is the First and Only Biologic to Offer Significant Survival Benefit as a First-Line Treatment with FOLFOX Chemotherapy for Patients with Wild-Type KRAS Metastatic Colorectal Cancer THOUSAND
BETHLEHEM, Pa., March 20, 2014 /PRNewswire/ -- Saladax Biomedical, Inc.
Researchers say a combination of bendamustine and rituximab may be just as effective and less toxic than standard chemotherapy for indolent lymphomas. Raleigh,
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.